Prenatal Diagnosis and Genetic Etiology of Fetal Polycystic Kidney Disease: A Single-Center Retrospective Study of 147 Cases in Yunnan Province, Southwest China
This single-center retrospective study of 147 fetal polycystic kidney disease cases in Yunnan, China, identified a genetic etiology in 34.7% of patients through a tiered diagnostic approach combining karyotyping, CNV-seq, and trio-WES, revealing trisomy 21, 17q12 deletions, and PKHD1/PKD1 mutations as the leading causes and providing critical regional data for prenatal counseling.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When a doctor looks at an ultrasound image of a developing baby, the kidneys usually appear as smooth, dark shapes. Sometimes, however, those shapes look different. They might be larger than expected, brighter than the surrounding tissue, or dotted with tiny fluid-filled sacs. This pattern, known as fetal polycystic kidney disease, is a common finding on mid-pregnancy scans. While the image shows a physical problem, it does not explain the cause. The condition can stem from a simple error in the number of chromosomes, a missing or extra piece of genetic material, or a specific change in a single gene. The cause matters immensely because it dictates the future. Some causes lead to severe illness or death shortly after birth, while others might not cause any health issues until adulthood. For parents facing this uncertainty, knowing the specific genetic reason behind the kidney changes is the only way to understand the likely outcome and make informed decisions about the pregnancy.
For years, doctors in many parts of the world have used a standard set of tests to hunt for these causes, but in Yunnan Province, a region in Southwest China with a rich mix of ethnic groups, such data was missing. Researchers at the Yunnan Provincial First People's Hospital decided to fill this gap by looking closely at 147 cases of fetal polycystic kidney disease diagnosed between 2020 and 2024. They treated each case like a puzzle, applying a two-step testing strategy designed to catch different types of genetic errors. First, they examined the chromosomes, the large packages that hold genetic instructions, and looked for missing or extra pieces of DNA using a method that scans the entire genome for large deletions or duplications. If those first tests came back clear, they moved to a second, deeper layer: sequencing the exome, which is the part of the DNA that contains the instructions for building proteins. This second step involved checking the DNA of the fetus alongside the DNA of both parents to spot tiny, single-letter changes that the first tests would miss.
The results of this large study revealed that a clear genetic cause could be found in about one-third of the cases. In 12 percent of the fetuses, the problem was a whole extra or missing chromosome, with the most common error being an extra copy of chromosome 21. In another 9.5 percent of cases, the issue was a large deletion of genetic material, and the most frequent culprit was a missing piece of chromosome 17 that removes a gene called HNF1B. This specific deletion, which affects kidney development and can lead to diabetes later in life, was found in ten cases, making it a major player in this region. When the researchers turned to the deeper genetic testing for the families who had passed the first round of checks, they found a diagnosis in nearly 60 percent of those groups. The most common single-gene causes were mutations in genes known as PKD1 and PKHD1, which are responsible for forms of polycystic kidney disease that run in families. Beyond these, the team identified rare genetic conditions affecting the tiny hair-like structures on cells, known as cilia, which are essential for the body's development.
The study also highlighted how these findings directly influenced the choices families made. Of the 51 families who received a confirmed genetic diagnosis, 44 chose to end the pregnancy. This decision was almost universal for cases involving extra chromosomes or severe syndromic conditions that affect multiple organs. However, the story was different for the families whose babies had a mutation in the PKD1 gene. Because this specific condition often does not cause symptoms until adulthood, four of the six families in that group decided to continue the pregnancy, planning for a child who would likely be healthy at birth but would need monitoring later in life. Despite the success of finding a cause in 34.7 percent of the total cases, the researchers noted that two-thirds of the families still did not have a definitive answer. This suggests that some genetic errors are too small or complex for current tests to catch, or that they involve parts of the DNA that do not code for proteins.
This work provides the first detailed map of genetic causes for fetal polycystic kidney disease in Yunnan, showing that the landscape of causes in this diverse region is similar to, yet distinct from, what is seen elsewhere. The researchers concluded that a two-step approach, starting with broad chromosome and large-deletion scans before moving to deep gene sequencing, offers the best chance for a diagnosis. While the technology has come a long way, the fact that many cases remain unsolved serves as a reminder that the human genome still holds many secrets. For the families in this study, the answers provided a path forward, allowing them to move from uncertainty to a clear understanding of their situation, whether that meant preparing for a difficult future or making plans for a child with a manageable condition.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.